Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery

被引:161
作者
Benoit, MA
Baras, B
Gillard, J
机构
[1] Catholic Univ Louvain, Ecole Pharm, Lab Pharm Galen Ind & Officinale, B-1200 Brussels, Belgium
[2] Inst Pasteur, Lab Relat Hote Parasite & Strategies Vaccinales, INSERM, U167, F-59019 Lille, France
关键词
poly(epsilon-caprolactone); biodegradable polymers; protein delivery system; protein microencapsulation; oral vaccine; emulsion-solvent evaporation method;
D O I
10.1016/S0378-5173(99)00109-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper describes the conditions of preparation of poly(epsilon-caprolactone) (PCL) microparticles with a mean size between 5 and 10 mu m, obtained by a double emulsion-solvent evaporation technique, suitable for oral vaccine delivery. Bovine serum albumin (BSA) was used as water-soluble model antigen for encapsulation. Different parameters influencing the microparticle size, the BSA loading and entrapment efficiency were investigated. Spherical, smooth and homogeneously distributed microparticles were produced with a BSA loading and entrapment efficiency reaching, respectively, 5% (w/w) and 30%. Polyacrylamide gel electrophoresis (PAGE) and isoelectric focusing (IEF) analyses of BSA released from these particles confirmed that the entrapped protein seemed to remain unaltered by the protein encapsulation process. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:73 / 84
页数:12
相关论文
共 27 条
[1]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[2]  
[Anonymous], 1994, NOVEL DELIVERY SYSTE
[3]   Single-dose mucosal immunization with biodegradable microparticles containing a Schistosoma mansoni antigen [J].
Baras, B ;
Benoit, MA ;
Dupré, L ;
Poulain-Godefroy, O ;
Schacht, AM ;
Capron, A ;
Gillard, J ;
Riveau, G .
INFECTION AND IMMUNITY, 1999, 67 (05) :2643-2648
[4]  
Benoit MA, 1998, BIOMEDICAL SCIENCE AND TECHNOLOGY, P137
[5]  
BENOIT MA, 1997, P INT S CONTR REL BI, V24, P817
[6]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[7]   CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].
ELDRIDGE, JH ;
HAMMOND, CJ ;
MEULBROEK, JA ;
STAAS, JK ;
GILLEY, RM ;
TICE, TR .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214
[8]  
GANDER B, 1993, P INT S CONTROL REL, V20, P65
[9]   RELEASE OF HUMAN SERUM-ALBUMIN FROM POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES [J].
HORA, MS ;
RANA, RK ;
NUNBERG, JH ;
TICE, TR ;
GILLEY, RM ;
HUDSON, ME .
PHARMACEUTICAL RESEARCH, 1990, 7 (11) :1190-1194
[10]   Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative study [J].
Jameela, SR ;
Suma, N ;
Jayakrishnan, A .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1997, 8 (06) :457-466